Items where Author is "Abdollahpour-Alitappeh, Meghdad"

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 9.

Article

Mohmmad-Rezaei, Mina and Arefnezhad, Reza and Ahmadi, Reza and Abdollahpour-Alitappeh, Meghdad and Mirzaei, Yousef and Arjmand, Mohammad-Hassan and Ferns, Gordon A. and Bashash, Davood and Bagheri, Nader (2020) An overview of the innate and adaptive immune system in atherosclerosis. IUBMB LIFE, 73 (1). pp. 64-91.

Yaghoubi, Sajad and Gharibi, Tohid and karimi, Mohammad Hossein and Sadeqi Nezhad, Muhammad and Seifalian, Alexander and Tavakkol, Reza and Bagheri, Nader and Dezhkam, Asiyeh and Abdollahpour-Alitappeh, Meghdad (2020) Development and biological assessment of MMAE-trastuzumab antibody–drug conjugates (ADCs). Breast Cancer. ISSN 1340-6868

Yaghoubi, Sajad and Najminejad, Hamid and Dabaghian, Mehran and Karimi, Mohammad Hossein and Abdollahpour-Alitappeh, Meghdad and Rad, Fariba and Mahi-Birjand, Motahareh and Mohammadi, Shiva and Mohseni, Fatemeh and Sobhani Lari, Mohammad and Teymouri, Gholam Hossein and Rigi Yousofabadi, Esmat and Salmani, Abbas and Bagheri, Nader (2020) How hypoxia regulate exosomes in ischemic diseases and cancer microenvironment? IUBMB Life. ISSN 15216543

Azadegan-Dehkordi, Fateme and Shirzad, Hedayatollah and Ahmadi, Reza and Bashash, Davood and Abdollahpour-Alitappeh, Meghdad and Luzza, Francesco and Larussa, Tiziana and Nahid-Samiei, Mahboobeh and Rahimian, Ghorbanali and Shafigh, Mohammad-Hadi and Bagheri, Nader (2020) Increased Indoleamine 2, 3-Dioxygenase expression modulates Th1/Th17/Th22 and Treg pathway in humans with Helicobacter Pylori-Infected gastric mucosa. Human Immunology. ISSN 01988859

Sarani, Ebrahim Moghimi and Ahmadi, Jamshid and Oji, Bahare and Mahi-Birjand, Motahareh and Bagheri, Nader and Bazrafshan, Amir and Manshadi, Marie Dehghan and Yaghoubi, Sajad and Dezhkam, Asiyeh and Khatami, Mehrdad and Abdollahpour-Alitappeh, Meghdad (2020) Investigating the sequential patterns of methamphetamine use initiation in Iran. Substance Abuse Treatment, Prevention, and Policy, 15 (1). ISSN 1747-597X

Najminejad, Hamid and Farhadihosseinabadi, Behrouz and Dabaghian, Mehran and Dezhkam, Asiyeh and Rigi Yousofabadi, Esmat and Najminejad, Reza and Abdollahpour-Alitappeh, Meghdad and Karimi, Mohammad Hossein and Bagheri, Nader and Mahi-Birjand, Motahareh and Ghasemi, Nasrin and Mazaheri, Mahta and Kalantar, Seyed Mehdi and Seifalian, Alexander and Sheikhha, Mohammad Hasan (2020) Key Regulatory miRNAs and their Interplay with Mechanosensing and Mechanotransduction Signaling Pathways in Breast Cancer Progression. Molecular Cancer Research. ISSN 1541-7786

Yaghoubi, Sajad and Karimi, Mohammad Hossein and Lotfinia, Majid and Gharibi, Tohid and Mahi-Birjand, Motahare and Kavi, Esmaeil and Hosseini, Fahimeh and Sineh Sepehr, Koushan and Khatami, Mehrdad and Bagheri, Nader and Abdollahpour-Alitappeh, Meghdad (2020) Potential drugs used in the antibody–drug conjugate (ADC) architecture for cancer therapy. Journal of Cellular Physiology, 235 (1). pp. 31-64. ISSN 00219541

Mahi-Birjand, Motahareh and Yaghoubi, Sajad and Abdollahpour-Alitappeh, Meghdad and Keshtkaran, Zahra and Bagheri, Nader and Pirouzi, Aliyar and Khatami, Mehrdad and Sineh Sepehr, Koushan and Peymani, Payam and Karimzadeh, Iman (2020) Protective effects of pharmacological agents against aminoglycoside-induced nephrotoxicity: A systematic review. Expert Opinion on Drug Safety, 19 (2). pp. 167-186. ISSN 14740338

Abdollahpour-Alitappeh, Meghdad and Lotfinia, Majid and Gharibi, Tohid and Mardaneh, Jalal and Farhadihosseinabadi, Behrouz and Larki, Pegah and Faghfourian, Babak and Sepehr, Koushan Sineh and Abbaszadeh-Goudarzi, Kazem and Abbaszadeh-Goudarzi, Ghasem and Johari, Behrooz and Zali, Mohammad Reza and Bagheri, Nader (2018) Antibody-drug conjugates (ADCs) for cancer therapy: Strategies, challenges, and successes. Journal of Cellular Physiology, 234 (5). pp. 5628-5642. ISSN 00219541

This list was generated on Mon Mar 8 01:26:02 2021 IRST.